{
    "code": "52026614",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026614",
    "time": "2021-12-17 03:38:26",
    "許可證字號": "衛部藥輸字第026614號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/09\/01",
    "發證\/登錄日期": "104\/09\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202661401",
    "中文品名": "艾亭寧膜衣錠400毫克",
    "英文品名": "Alvotinib 400mg Film-Coated tablets",
    "適應症": "治療正值急性轉化期（BLAST CRISIS）、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病（CML）患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷慢性骨髓性白血病（CML）的病人。治療初診斷為費城染色體陽性急性淋巴性白血病（Ph+ALL）且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病（Ph+ALL）之單一療法。治療患有與血小板衍生生長因子體（PDGFR）基因重組相關之骨髓發育不全症候群（MDS）／骨髓增生性疾病（MPD）之成人患者。治療患有系統性肥大細胞增生症（SM），限具FIP1L1-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。治療嗜伊紅性白血球增加症候群（HES）與／或慢性嗜伊紅性白血病（CEL）且有血小板衍生生長因子受體（PDGFR）基因重組之成人患者。作為成人KIT（CD 117）陽性胃腸道基質瘤完全切除後（complete gross resection）之術後輔助治療。治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體（PDGFR）基因重組之隆突性皮膚纖維肉瘤（DFSP）之成人患者。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠PVC\/PE\/PVDC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "IMATINIB MESYLATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "申請商地址": "台北市信義區松仁路277號17樓",
    "主製造廠": [
        {
            "": "CYPRUS",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "0901314300  美時化學製藥股份有限公司南投廠",
            "製造廠廠址": "南投縣南投市新興里成功一路３０號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000710",
            "成分名稱": "IMATINIB MESYLATE",
            "含量描述": "(Equivalent to Imatinib 400mg)",
            "含量": "478.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "52026614-104-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026614&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "艾亭寧_仿單-109-05-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026614&Seq=004&Type=9"
        },
        {
            "title": "ArtworkProof_CompID_17813_Round_2_ARTDB016820F(done)_400mg-110-02-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026614&Seq=007&Type=8"
        },
        {
            "title": "ArtworkProof_CompID_17812_Round_3_ARTDB016819C_400mg-110-02-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026614&Seq=006&Type=8"
        },
        {
            "title": "ALVOTINIB 400mg-P01.0705.400WB.40A-eye mark-95x57mm_ARTDB016820F-109-11-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026614&Seq=005&Type=8"
        },
        {
            "title": "ALVOTINIB 400 30 TABS (RM 607 A)_ARTDB016819C-109-11-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026614&Seq=004&Type=8"
        },
        {
            "title": "52026614-3-104-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026614&Seq=003&Type=8"
        }
    ]
}